Surgical outcome of conjunctival rotational autograft-mitomycin C (MMC) versus free conjunctival autograft-MMC for pterygium removal

A randomized clinical trial

Authors

  • Masoud Yasemi Poostchi Ophthalmology Research Center, Department of Ophthalmology, Shiraz University of Medical Sciences, Shiraz, Iran , Health Research Center, Life Style Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran

Keywords:

Pterygium, Conjunctival rotation autograft (CRA), Conjunctival autograft (CA)

Abstract

Background: Pterygium is a common degenerative eye disease. Despite various surgical methods to treat pterygium, recurrence is the main complication. The main issue is finding a surgical method with the lowest recurrence.

Objective: to compare the complications, recurrence rate and the cosmetic effects of two surgical techniques, namely conjunctival rotation autograft (CRA) and conjunctival autograft (CA), in treating pterygium.

Methods: This randomized clinical trial was conducted at Khalili Hospital in Shiraz, Iran, from January to August 2015. Forty-five eyes from 45 patients were studied. The patients were randomly divided into two groups using the blocking method. The patients of one group were operated on by the CRA technique, while the other group was operated on by the CA method. The patients were checked for the recurrence of pterygium, and other complications at the end of the first, third, and sixth month. Finally, the data were analyzed using SPSS version 21.

Results: The mean age of the patients was 42.5 years. The recurrence of pterygium was not observed in any of the patients 6 months after the surgery. Following 6 months after the operation, graft retraction occurred during the first week for one patient (4.5%) in the CA group, and five patients (21.7%) in the CRA group. The prevalence rate of graft injection among the patients of the CA and CRA groups 6 months after the operation was 9.1% and 65.2%, respectively. There was a significant correlation between injection intensity and the dissatisfaction of the patients with the operation’s outcome (p=0.017).

Conclusion: CRA with mitomycin is considered as an effective method to reduce the recurrence of pterygium after operation. This technique can be used as an acceptable method for pterygium operation, especially for patients with insufficient conjunctiva.

Clinical trial registration: The trial was registered at the Iranian Registry of Clinical Trials (http://www.irct.ir) with the Irct ID: IRCT2016092119581N2.

Funding: The study was financially supported by Shiraz University of Medical Sciences (SUMS) (grants No. 8901).

References

Droutsas K, Sekundo W. Epidemiology of pterygium: a review article. Ophthalmology. 2010; 107: 511–6.

doi: 10.1007/s00347-009-2101-3. PMID: 20393731.

Alpay A, Uğurbaş SH, Erdoğan B. Comparing techniques for pterygium surgery. Clin Ophthalmol. 2009;

: 69-74. PMID: 19668546, PMCID: PMC2709008.

Fernandes M, Sangwan VS, Bansal AK. Outcome of pterygium surgery: analysis over 14 years. Eye. 2005;

: 1182–90. doi: 10.1038/sj.eye.6701728.

Paracha Q, Ayoob M, Dawood Z, Mirza SA. Recurrence rate with use of intraoperative Mitomycin C

versus Conjunctivalautograft following pterygium excision. Pak J Med Sci. 2014; 30: 1243-6. doi:

12669/pjms.306.5191.

Ari Ş, Çaca Î, Yildiz ZÖ, Şakalar YB, Dogan E. Comparison of mitomycin C and limbal- conjunctivalautograft in the prevention of pterygium recurrence in Turkish patients: a one-year,

randomized, assessor-masked, controlled trial. Curr Ther Res Clin Exp. 2009; 70: 274–81. doi:

1016/j.curtheres.2009.08.004. PMID: 24683237, PMCID: PMC3967336.

Frucht-Pery J, Siganos CS, Ilsar M. Intraoperative application of topical mitomycin C for pterygium

surgery. Ophthalmology. 1996; 103: 674–7. doi: 10.1016/S0161-6420(96)30635-0. PMID: 8618770.

Jap A, Chan C, Lim L, Tan DT. Conjunctival Rotation Autograft for Pterygium, An Alternative to

Conjunctival Autografting. Ophthalmology. 1999; 106: 67–71. doi: 10.1016/S0161-6420(99)90006-4.

PMID: 9917783.

Spaeth ED. Rotated Island graft operation for pterygium. Am J Ophthalmol. 1926; 9: 649–55. doi:

1016/S0002-9394(26)90475-3.

Alp BN, Yanyali A, Ay GM, Keskin O. Conjunctival rotation autograft forprimary pterygium.

Ophthalmologica. 2002; 216: 333-6. doi: 10.1159/000066188.

Young AL, Tam PM, Leung GY, Cheng LL, Lam PT, Lam DS. Prospective Study on the Safety and

Efficacy of Combined Conjunctival Rotational Autograft with Intraoperative 0.02% Mitomycin C in

Primary Pterygium Excision. Cornea. 2009; 28: 166-9. doi: 10.1097/ICO.0b013e318187544d.

Wu WK, Wong VW, Chi SC, Lam DS. Surgical management of double-head pterygium by using a novel

technique: conjunctival rotational autograft combined with conjunctivalautograft. Cornea. 2007; 26: 1056- 9. doi: 10.1097/ICO.0b013e31813349ec. PMID: 17893533.

Mutlu FM, Sobaci G, Tatar T, Yildirim E. A comparative study of recurrent pterygium surgery: limbal

conjunctival autograft transplantation versus mitomycin C with conjunctival flap. Ophthalmology. 1999;

: 817–21. PMID: 10201608.

Haider TA, Al-Amin LM, Bamashmus MA, Ali SF. Ninety degree conjunctival rotation autograft versus

zero and 180 degree rotation autograft for pterygium surgery. Saudi Med J. 2009; 30: 519-23. PMID:

Seid A, Bejiga A. Free conjunctivalautograft in the management of advanced primary and recurrent

pterygia. East Afr Med J. 2000; 77: 588-91. PMID: 12862103.

Sharma A, Gupta A, Ram J. Low-dose intraoperative mitomycin-C versus conjunctivalautograft in primary

pterygium surgery: long term follow-up. Ophthalmic Surg Lasers. 2000; 31: 301-7. PMID: 10928667.

Paracha Q, Ayoob M, Dawood Z, Mirza SA. Recurrence rate with use of intraoperative Mitomycin C

versus ConjunctivalAutograft following pterygium excision. Pak J Med Sci. 2014; 30: 1243-6. doi:

12669/pjms.306.5191. PMID: 25674116, PMCID: PMC4320708.

Keklikci U, Celik Y, Cakmak SS, Unlu MK, Bilek B. Conjunctival-limbalautograft, amniotic membrane

transplantation, and intraoper- ativemitomycin C for primary pterygium. Ann Ophthalmol (Skokie). 2007;

: 296-301. PMID: 18025649.

Tananuvat N, Martin T. The results of amniotic membrane transplantation for primary pterygium compared

with conjunctival-autograft. Cornea. 2004; 23: 458-63. PMID: 15220729.

Frucht-Pery J, Raiskup F, Ilsar M, Landau D, Orucov F, Solomon A. Conjunctivalautografting combined

with low-dose mitomycin C for prevention of primary pterygium recurrence. Am J Ophthalmol. 2006;

(6): 1044-50. PMID: 16546105.

Segev F, Jaeger-Roshu S, Gefen-Carmi N, Assia EI. Combined mitomycin C application and free flap

conjunctival -autograft in pterygium surgery. Cornea. 2003; 22: 598-603. doi: 10.1097/00003226- 200310000-00003. PMID: 15502489.

UçakhanO, Kanpolat A. Combined "symmetrical conjunctival flap transposition" and intraoperative low- dose mitomycin C in the treatment of primary pterygium. Clin Experiment Ophthalmol. 2006; 34: 219-25.

PMID: 16671901.

Dadeya S, Malik KP, Gulliani BP. Pterygium surgery: conjunctival rotation autograft versus

conjunctivalautograft. Ophthalmic Surgery, Lasers and Imaging Retina. 2002; 33: 269-74. PMID:

Figueira E, Coroneo M, Francis I. Preventing conjunctivalautograft inversion in pterygium surgery. Br J

Ophthalmol. 2007; 91: 83-4. doi: 10.1136/bjo.2006.102905. PMID: 17179124, PMCID: PMC1857570.

Elwan SA. Comparison between sutureless and glue free versus sutured limbalconjunctivalautograft in

primary pterygium surgery. Saudi J Ophthalmol. 2014; 28: 292–8. doi: 10.1016/j.sjopt.2014.03.012. PMID:

, PMCID: PMC4250493.

McCarty CA, Fu CL, Taylor HR. Epidemiology of pterygium in Victoria, Australia. Br J Ophthalmol.

; 84: 289-92. PMID: 10684840.

Shiroma H, Higa A, Sawaguchi S. Prevalence and risk factors of pterygium in a southwestern island of

Japan: the Kumejima Study. Am J Ophthalmol. 2009; 148: 766-71. PMID: 19664753.

Jiao W, Zhou C, Wang T, Yang S, Bi H, Liu L, et al. Prevalence and risk factors for pterygium in rural

older adults in Shandong Province of China: a cross-sectional study. Biomed Res Int. 2014; 2014: 658648.

doi: 10.1155/2014/658648. PMID: 25165711, PMCID: PMC4140101.

Anguria P, Kitinya J, Ntuli S, Carmichael T. The role of heredity in pterygium development. Int J

Ophthalmol. 2014; 7: 563-73. doi: 10.3980/j.issn.2222-3959.2014.03.31. PMID: 24967209, PMCID:

PMC4067677.

Maheshwari S. Pterygium-induced corneal refractive changes. Indian J Ophthalmol. 2007; 55: 383-6.

PMID: 17699952.

Altan-Yaycioglu R, Kucukerdonmez C, Karalezli A. Astigmatic changes following pterygium removal:

Comparison of 5 different methods. Indian J Ophthalmol. 2013; 61: 104-8. doi: 10.4103/0301- 4738.109379.

Published

2022-02-12